Seagen
SGEN
#546
Rank
ยฃ32.39 B
Marketcap
ยฃ171.70
Share price
-0.07%
Change (1 day)
61.79%
Change (1 year)

Revenue for Seagen (SGEN)

Revenue in 2023 (TTM): ยฃ1.86 Billion

According to Seagen 's latest financial reports the company's current revenue (TTM ) is ยฃ1.72 Billion. In 2022 the company made a revenue of ยฃ1.62 Billion an increase over the revenue in the year 2021 that were of ยฃ1.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seagen from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ1.86 B14.93%
2022 ยฃ1.62 B39.08%
2021 ยฃ1.16 B-26.92%
2020 ยฃ1.59 B128.31%
2019 ยฃ0.69 B35.54%
2018 ยฃ0.51 B44.55%
2017 ยฃ0.35 B5.29%
2016 ยฃ0.33 B49.11%
2015 ยฃ0.22 B23.39%
2014 ยฃ0.18 B12.83%
2013 ยฃ0.16 B25.15%
2012 ยฃ0.13 B113.89%
2011 ยฃ60.97 M-12.41%
2010 ยฃ69.61 M116.79%
2009 ยฃ32.11 M33.57%
2008 ยฃ24.04 M113.03%
2007 ยฃ11.28 M120.95%
2006 ยฃ5.1 M-9.72%
2005 ยฃ5.65 M62.1%
2004 ยฃ3.49 M23.14%
2003 ยฃ2.83 M169.94%
2002 ยฃ1.05 M455.35%
2001 ยฃ0.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ImmunoGen
IMGN
ยฃ0.21 B-87.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ7.55 B 337.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.95 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ19.31 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 2,629.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.79 B 1,741.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
ยฃ44.77 B 2,492.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.05 B 1,988.12%๐Ÿ‡บ๐Ÿ‡ธ USA